Showing results (81-90 of 818) with videos related to
Sort By:
Pageof 82
Lipids|July 6, 2004
Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fatDeepa Sankaran, Jing Lu, Neda Bankovic-Calic, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 3, 2001
Creatine supplementation increases renal disease progression in Han:SPRD-cy ratsJ W Edmunds, S Jayapalan, N M DiMarco, et al.Molecular Nutrition & Food Research|October 31, 2013
Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy ratNaser H M Ibrahim, Yong Jia, Jessay G Devassy, et al.American Journal of Physiology. Heart and Circulatory Physiology|August 13, 2017
Dietary modulation of oxylipins in cardiovascular disease and agingStephanie P B Caligiuri, Mihir Parikh, Aleksandra Stamenkovic, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 17, 2014
Dietary flax oil rich in α-linolenic acid reduces renal disease and oxylipin abnormalities, including formation of docosahexaenoic acid derived oxylipins in the CD1-pcy/pcy mouse model of nephronophthisisTamio Yamaguchi, Jessay G Devassy, Melissa Gabbs, et al.Genes|August 28, 2019
Opportunities and Challenges in Interpreting and Sharing Personal GenomesIrit R Rubin, Gustavo GlusmanDiabetes Technology & Therapeutics|December 3, 2011
Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trialRichard R Rubin, Mark Peyrot, Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 1994
Hepatic fibrosis associated with hereditary cystinosis: a novel form of noncirrhotic portal hypertensionP J Klenn, R RubinHealth and Quality of Life Outcomes|March 26, 2010
Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)Richard R Rubin, Mark PeyrotDiabetes Care|December 24, 2004
Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating QuestionnaireMark Peyrot, Richard R RubinPageof 82